Web CRG
  1. Home
  2. Industry & Investors
  3. License CRG Technologies
  4. Technology Publisher

License CRG Technologies

Explore our Technology Portfolio

If you are exploring licensing opportunities at the CRG, the TBDO can guide you to a wide range of suitable researchers and their technologies.

Search Results - tobias+hoffmann

1 Results Sort By:
Novel Targets and Compounds to Treat Bladder Cancer
Alternative splicing modulating antisense oligonucleotides (ASOs) targeting novel identified alternative splicing changes associated with RBM10 mutations in bladder cancer. We are developing lead ASOs to treat bladder, and eventually other, cancers. Technology: Bladder cancer is the 9th most common malignant disease worldwide and 13 most frequent...
Published: 8/6/2025   |   Inventor(s): Juan Valcarcel, Ángel Guerra, Tobias Hoffmann
Keywords(s):  
Category(s): Biotechnology, Drug Targets & Mechanisms, Therapeutics (Biologics & Compounds)

 

 

Categories

Featured Technologies

Most Popular Keywords

Latest Technologies Published

Search our database for an up-to-date listing of CRG intellectual property available for licensing